KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Gains from Investment Securities (2016 - 2026)

NovoCure's Gains from Investment Securities history spans 13 years, with the latest figure at -$2.0 million for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities rose 20.79% to -$2.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $46.5 million, a 51.82% increase, with the full-year FY2025 number at $30.7 million, up 30.73% from a year prior.
  • Gains from Investment Securities hit -$2.0 million in Q1 2026 for NovoCure, down from $37.2 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for NVCR hit a ceiling of $37.2 million in Q4 2025 and a floor of -$11.0 million in Q4 2022.
  • Historically, Gains from Investment Securities has averaged $6.1 million across 5 years, with a median of $2.9 million in 2024.
  • Biggest five-year swings in Gains from Investment Securities: surged 1160.56% in 2022 and later plummeted 240.42% in 2023.
  • Tracing NVCR's Gains from Investment Securities over 5 years: stood at -$11.0 million in 2022, then skyrocketed by 296.09% to $21.6 million in 2023, then surged by 45.2% to $31.4 million in 2024, then grew by 18.2% to $37.2 million in 2025, then crashed by 105.5% to -$2.0 million in 2026.
  • Business Quant data shows Gains from Investment Securities for NVCR at -$2.0 million in Q1 2026, $37.2 million in Q4 2025, and -$2.5 million in Q3 2025.